| Folate supplementation in pregnancy |
| Folate supplementation in women of reproductive age |
| Folic acid for fragile X syndrome |
| Folic acid or folinic acid for reducing side effects of methotrexate for people with rheumatoid arthritis |
| Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas |
| Folic acid supplementation for the prevention of anaemia in preterm neonates |
| Folic acid supplementation in pregnancy |
| Folic acid supplements before conception and in early pregnancy (up to 12 weeks) for the prevention of birth defects |
| Follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in assisted reproduction cycles |
| Follicular flushing during oocyte retrieval in assisted reproductive technology |
| Follow-up approaches after abortion at 14 gestation weeks or later |
| Follow-up for improving psychological well being for women after a miscarriage |
| Follow-up of precancerous conditions of the stomach to prevent cancer development |
| Follow-up services to improve the long-term after-effects of a stay in the intensive care unit |
| Follow-up strategies after completion of primary cancer treatment |
| Follow-up strategies for participants treated for non-metastatic colorectal cancer |
| Follow-up strategies for women following treatment for CIN: Impact of HPV testing |
| Follow-up strategies for women with endometrial cancer after primary treatment |
| Food supplementation for improving the physical and psychosocial health of socio-economically disadvantaged children aged three months to five years |
| Food-based calcium or vitamin D or both for osteoporosis in postmenopausal women |
| Food-based oral rehydration solution for acute diarrhoea |
| Foot orthoses for treating flat feet in children |
| For a person with a head injury who is in a coma, are there benefits to regularly monitoring the pressure inside the skull? |
| For people with chronic asthma, is a single combination inhaler for both regular and "as-needed" treatment better than two separate inhalers? |
| For people with COPD, is it better to take a combination of tiotropium and long-acting beta2-agonists than either inhaler alone? |
| For people with uncontrolled asthma on inhaled steroids, is it better to increase the dose or add a long-acting muscarinic antagonist? |
| Force platform feedback for standing balance training after stroke |
| Formal education of patients about to undergo laparoscopic cholecystectomy |
| Former South African Minister of Finance will open the Global Evidence Summit |
| Formoterol and budesonide for the relief of asthma symptoms in adults and children |
| Formoterol versus short-acting beta-agonists as symptom relief for adults and children with asthma |
| Formula versus donor breast milk for feeding preterm or low birth weight infants |
| Formula versus maternal breast milk for feeding preterm or low birth weight infants |
| Formulas containing hydrolysed protein for prevention of allergic disease in infants |
| Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma |
| Forns index and 'FIB4' for staging of fibrosis in adults with chronic hepatitis C |
| Fortification of maize flour with iron for preventing anaemia and iron deficiency |
| Fortification of rice with vitamins and minerals for addressing micronutrient malnutrition |
| Fortification of salt with iron and iodine compared to salt fortified with iodine only for improving iron and iodine status |
| Fortification of staple foods with vitamin A for vitamin A deficiency |
| Foscarnet for chronic hepatitis B |
| Founder of Cochrane Skin, Professor Hywel Williams, awarded the Order of the British Empire |
| Founding member of Cochrane, Dr. Peter Tugwell, receives the 2020 CIHR Barer-Flood Prize |
| Four major policy issues for Cochrane: recent correspondence with the Governing Board |
| Four new WHO recommendations supported by Cochrane Pregnancy and Childbirth reviews and ‘living guideline’ approach |
| Fraction size in radiation therapy for breast conservation in early breast cancer |
| Fracture repair compared with partial or total joint replacement for treating hip fractures located within the hip joint |
| Framing of the health information message in either negative or positive words |
| Free Access to Cochrane’s COVID-19 pandemic resources guaranteed |
| Free educational videos demystify systematic reviews |
| Free Webinar: From Evidence of Overuse to De-implementation |
| Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients |
| Frequency of suctioning inside the tube that is used to ventilate newborn babies |
| Fresh frozen plasma for patients undergoing surgery on the heart or blood vessels |
| Fresh versus frozen embryo transfers for assisted reproduction |
| Friday's Virtual Colloquium #CochraneSantiago content! |
| From Cluttered to Clear: Presenters and attendees to benefit from Cochrane London Colloquium's adoption of #betterposter templates |
| From complexity to clarity: Cochrane unveils #BetterPresentations templates for accessible and engaging talks at the Cochrane London Colloquium |
| From complexity to clarity: Research shows benefit of #betterposter templates at Cochrane Colloquium |
| From experience to expertise: Patients lead as authors in Cochrane's widely-used breast cancer review |
| Fructose substitution of glucose or sucrose in food for normoglycaemic persons or people with impaired glucose tolerance or diabetes |
| FTY720 immunosuppression for kidney transplant recipients |
| Full publication of results initially presented in abstracts |
| Fulvestrant in the treatment of postmenopausal women with advanced hormone-sensitive breast cancer |
| Functional capacity evaluations for preventing re-injuries in employees on returning to work |
| Functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis |
| Functional Family Therapy for families of youth (age 11-18) with behaviour problems |
| Fundal pressure during the second stage of labour for improving maternal and fetal outcomes |
| Fundal pressure versus controlled cord traction as part of the active management of the third stage of labour |
| Funding available for LMIC participants at Cochrane Colloquium |
| Furosemide for prevention of morbidity in indomethacin-treated infants with patent ductus arteriosus |
| Further extension to abstract and workshop submission date |
| Further trials are necessary to find the optimal method of vascular occlusion in liver resection |
| Fusion techniques for degenerative disc disease |
| Fusion versus conservative management for low-grade isthmic spondylolisthesis |
| G-CSF and GM-CSF for treating or preventing neonatal infections |
| G. lucidum (Reishi mushroom) for cancer treatment |
| Gabapentin as an add-on for drug-resistant focal epilepsy |
| Gabapentin for acute postoperative pain in adults |
| Gabapentin for chronic neuropathic pain in adults |
| Gabapentin for pain in adults with fibromyalgia |
| Gabapentin for the treatment of acute and chronic pain in adults |
| Gabapentin monotherapy for epilepsy |
| Gabapentin monotherapy for epilepsy |
| Gabapentin or pregabalin for preventing migraine attacks in adults |
| Gabapentinoids for chronic post-thoracotomy pain after lung surgery in adults |
| Galantamine improves global and cognitive symptoms at doses of 16 mg/day or greater, in people with mild to moderate Alzheimer's disease, for at least 6 months |
| Galantime for dementia in people with Down syndrome |
| Gamma aminobutyric acid (GABA) receptor agonists for acute stroke |
| Gamma aminobutyric acid modulators for amyotrophic lateral sclerosis/motor neuron disease |
| Gamma-amino butyric acid (GABA) receptor agonists for gastroesophageal reflux disease (GERD) |
| Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia |
| Gamma-hydroxybutyrate for treating symptoms associated with alcohol withdrawal and preventing relapses for people who are dependent on alcohol |
| Ganaxolone add-on for drug-resistant epilepsy |
| Gangliosides for acute ischaemic stroke |
| Gangliosides for the treatment of diabetic peripheral neuropathy |
| Ganoderma lucidum mushroom (lingzhi/reishi) for treating cardiovascular risk factors |
| Gardening activity as a therapy for schizophrenia |
| Garlic for diabetes mellitus |
| Garlic for Hypertension |
| Garlic for peripheral arterial occlusive disease affecting the legs |
| Garlic for preventing pre-eclampsia and its complications |
| Garlic for the common cold |
| Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults |
| Gastrografin for treatment of meconium obstruction in term and preterm infants |
| Gastrostomy plus fundoplication or gastro-jejunal tube versus gastrostomy alone for gastro-esophageal reflux in children with neurological impairment |
| Gemcitabine for non-small cell lung cancer |
| Gemcitabine for platinum-resistant or recurrent ovarian cancer |
| Gemcitabine for unresectable, advanced or metastatic bladder cancer |
| Gemcitabine-containing chemotherapy for people with advanced bile duct cancer |
| Gender differences in health literacy of migrants: a synthesis of qualitative evidence |
| Gene therapy for haemophilia |
| Gene therapy for people with hepatocellular carcinoma |
| Gene therapy for peripheral arterial disease |
| Gene therapy for peripheral arterial disease |
| Gene therapy for sickle cell disease |
| General health checks for reducing illness and mortality |
| General physical health care advice for people with serious mental illness |
| General strengthening exercise for chronic low back pain |
| General versus loco-regional anaesthesia for endovascular aneurysm repair |
| Generic versus branded antiepileptic drug monotherapy for epilepsy |
| Generic versus non-generic prescribing for epilepsy |
| Genetic testing for predicting and preventing severe skin rashes caused by drugs |
| Genital ulcer disease treatment for reducing sexual acquisition of HIV |
| Genotypic antiretroviral resistance testing at viral failure in people with HIV |
| Gentamicin dosage in neonates |
| Gentamicin-impregnated collagen implants for the reduction of surgical site infections |
| Get limited edition #CochraneLondon items before the Colloquium – explore the collection! |
| Get ready for #CochraneLondon: Top tips from the Cochrane Community |
| Get ready for the 2023 Cochrane Colloquium: view the full programme and build your schedule |
| Get Social with Cochrane! |
| Get up, stand up: new review looks at reducing sedentary behaviour in older adults |
| Ghrelin, a hunger hormone for management of cancer patients with loss of appetite and weight loss |
| Gingival retraction for fixed prosthodontic treatment |
| Ginkgo biloba for acute ischaemic stroke |
| Ginkgo biloba for cognitive impairment and dementia |
| Ginkgo biloba for cognitive improvement in healthy individuals |
| Ginkgo biloba for people with leg pain while walking (intermittent claudication) |
| Ginkgo biloba for tinnitus |
| Ginkgo biloba herbal supplement for tinnitus |
| Ginkgo biloba versus placebo for schizophrenia |
| Ginseng for improving erectile function |
| Ginseng for improving the quality of life in people with cancer |
| Ginseng for preventing and treating the common cold |
| Giving additional fluid to newborn infants having phototherapy for serious jaundice |
| Giving aminoglycoside antibiotics intravenously once daily compared to giving them several times per day in people with cystic fibrosis |
| Giving antibiotics regularly to people with cystic fibrosis to prevent lung infection with a germ called |
| Giving blood pressure-lowering drugs around the time of surgery to reduce the risk of death and serious illness in adults |
| Giving glutamine supplements to critically ill adults |
| Giving healthcare consumers a platform to be heard |
| Giving intravenous nutrients to adults during surgery to prevent hypothermia |
| Giving iron supplements to improve outcomes in children with HIV/AIDS |
| Giving less oral or intravenous fluid to newborn infants with breathing difficulty (transient tachypnea of the newborn) |
| Giving magnesium maintenance therapy to women to prevent preterm birth after stopping threatened preterm labour |
| Giving melatonin to women in pregnancy to protect the baby's brain and improve long-term outcomes for the baby |
| Giving routine respiratory synctial virus immunoglobulin to premature babies can help reduce hospitalisation and admission to intensive care |
| Giving women their own case notes to carry during pregnancy |
| Glasses to prevent eye misalignment (strabismus) in far-sighted children |
| Glaucoma drainage devices versus trabeculectomy for lowering intraocular pressure in people of West African origin |
| Global Evidence Summit 2017: Call for abstracts extended to 15 March |
| Global Evidence Summit – Postponed to 9 – 13 September 2024 |
| Global evidence, local impact: broadening participation at the Global Evidence Summit |
| Global rollout of rapid molecular tests for tuberculosis over the last 12 years: Cochrane Review summarizes research on recipient and provider views |
| Glucagon-like peptide (GLP)-1 analogues as an add-on to insulin for adults with type 1 diabetes mellitus |
| Glucagon-like peptide (GLP)-1 analogues for normoglycaemic, overweight or obese adults |
| Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes |
| Glucagon-like peptide analogues for type 2 diabetes |
| Glucagon-like peptide-1 analogues for overweight or obese adults |
| Glucocorticoid injections for lateral elbow pain |
| Glucocorticoid replacement regimens in the treatment of 21-hydroxylase deficiency congenital adrenal hyperplasia |
| Glucocorticoid supplementation for IVF/ICSI |
| Glucocorticoids for acute viral bronchiolitis in infants and young children under two years of age |
| Glucocorticoids for croup in children |
| Glucocorticoids for decompensated heart failure |
| Glucocorticoids for rheumatoid arthritis |
| Glucocorticoids for the treatment of anaphylaxis |
| Glucocorticosteroid pretreatment may increase virologic response to interferon in hepatitis B 'e' antigen positive chronic hepatitis B |
| Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients |
| Glucocorticosteroids administered after Kasai surgical procedure for infants with blocked or damaged bile duct |
| Glucocorticosteroids for people with alcoholic hepatitis |
| Glucocorticosteroids for viral hepatitis B |
| Glucocorticosteroids on post-operative nausea and vomiting for patients undergoing laparoscopic cholecystectomy |
| Glucosamine for osteoarthritis |
| Glucose for the management of procedural pain in neonates |
| Glucose targets for preventing diabetic kidney disease and its progression |
| Glucose-6-phosphate dehydrogenase deficiency near-patient tests for tafenoquine or primaquine use with Plasmodium vivax malaria |
| Glucose-insulin-potassium (GIK) and tight-glycaemic-control (TGC) versus standard therapy insulin for critically ill patients |
| Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients |
| Glucose-lowering medications to treat diabetes and chronic kidney disease |
| Glue may be a sensible alternative to suture for mesh fixation in Lichtenstein inguinal hernioplasty |
| Glutamate receptor antagonists for tinnitus |
| Glutamatergic drugs for schizophrenia |
| Glutamine for treatment of active Crohn's disease |
| Glutamine supplementation for young infants with severe gastrointestinal disease |
| Glutamine supplementation in enteral or parenteral nutrition for the incidence of mucositis in colorectal cancer |
| Glutamine supplementation to prevent morbidity and mortality in preterm infants |
| Gluten and casein-free diets for autism spectrum disorder |
| Glycaemic control for patients with acute coronary syndrome |
| Glycerin laxatives for prevention or treatment of feeding intolerance in very low birth weight infants |
| Glycerol for acute stroke |
| Glyceryl trinitrate patches for rotator cuff disease |
| Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke |
| Glycopyrronium bromide for chronic obstructive pulmonary disease |
| Glycyrrhizin for chronic hepatitis B virus infection |
| Glycyrrhizin versus antiviral drugs for chronic hepatitis B virus infection |
| GnRH agonists for uterine fibroids |
| Goal setting for adults receiving clinical rehabilitation for disability |
| Goal-directed fluid management for reduction of gastrointestinal complications in adults undergoing major abdominal surgery |
| Gold may have a small impact on asthma for people dependent on corticosteroids, but adverse effects are serious and a lot of monitoring is needed. |
| Golimumab for rheumatoid arthritis |
| Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome |
| Gonadotrophin-releasing hormone agonist for improving fertility |
| Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles |
| Gonadotrophin-releasing hormone agonists (GnRHa) used as an adjuvant to gonadotrophins in assisted reproduction treatments |
| Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome |
| Gonadotrophin-releasing hormone analogues for pain associated with endometriosis |
| Gonadotrophin-releasing hormone analogues for pain associated with endometriosis |
| Gonadotrophin-releasing hormone analogues for pain associated with endometriosis |
| Gonadotrophin-releasing hormone antagonists versus GnRH agonist in subfertile couples undergoing assisted reproductive technology |
| Gonadotrophine Releasing Hormone antagonists for the treatment of endometriosis |
| Gonadotrophins for idiopathic male factor subfertility |
| Gonadotrophins to induce ovulation in women with polycystic ovary syndrome (PCOS) |
| Gonadotropin-releasing hormone (GnRH) analogues for premenstrual syndrome (PMS) |
| Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology cycles |
| Gonadotropin-releasing hormone analogues for women with ovarian cancer undergoing chemotherapy |
| Google Scholar to identify research studies |
| Governance and management |
| Governing Board elections December 2018: Results |
| Governing Board elections November 2018: Announcing the candidates standing |
| Governing Board elections November 2018: Interviews with the candidates |
| Government lockdown and mental health outcomes in the general population |
| Government regulation of private health insurance |
| Government regulation, training, or co-ordination of private for-profit health care in low- and middle-income countries |
| Gowning by attendants and visitors in newborn nurseries for prevention of neonatal morbidity and mortality |
| Gradual versus abrupt discontinuation of oxygen in preterm or low birth weight infants |
| Graduated compression stockings for prevention of deep vein thrombosis during a hospital stay |
| Graduated driver licensing for reducing motor vehicle crashes among young drivers |
| Graft nephrectomy for people with a failed kidney transplant |
| Graft type for open abdominal aortic surgery |
| Grafts for preventing Frey's syndrome after surgery to the parotid (salivary) glands |
| Grant giving relies heavily on peer review for the assessment of the quality of proposals but the evidence of effects of these procedures is scarce |
| Grant to enhance evidence-informed guideline recommendations for newborn and young child health in three sub-Saharan African countries |
| Granulocyte colony stimulating factor (G-CSF), when given with antibiotics, does not appear to reduce mortality in adults with pneumonia |
| Granulocyte colony stimulating factor treatment following a heart attack |
| Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease |
| Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia |
| Granulocyte-colony stimulating factor for acute liver failure or acute-on-chronic liver failure |
| Granulocyte-colony stimulating factor, a growth factor, which can be added to usual therapy for treating foot infections in people with diabetes |
| Granulopoiesis-stimulating factors for preventing infections after autologous peripheral stem cell transplantation for lymphoma and multiple myeloma in adults |
| Granulopoiesis-stimulating factors in the prevention of adverse effects during the therapeutic treatment of malignant lymphoma. |
